RxDoctor Payments Data

Matthew Garrison, DPM

Primary Podiatric Medicine · Sacramento, CANPI 1801808332

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (53.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 50.1% of the total. Reporting peaked in 2022 at $4,024 and has fallen 98.9% since, to $46 in 2025. Among primary podiatric medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,724in general payments, 2019–2025

Across 53 payments — averaging $126.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3K
  • Sequoia Surgical, Inc.$1K
  • Stryker$713
  • Evolution Surgical, Inc$369
  • Bioventus LLC$284
  • Integra Lifesciences Corporation$210
  • plus $507 from 11 others

What the payments were for

  • Travel & lodging$4286%
  • Food & beverage$2,69740%
  • Education$3,60054%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,724 in reported general payments places this provider in the 90th percentile of 59 primary podiatric medicine providers in California.

See all primary podiatric medicine providers in California

Medicare billing

Part B allowed, 2024
$130,801
Medicare patients
343
Services billed
1,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin109$1,875
Ciclopirox26$1,159
Clotrimazole14$604
Pregabalin21$530
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$374
Ammonium Lactate20$372
Terbinafine Hcl22$361
Ropinirole Hcl13$298
Cyclobenzaprine Hcl34$235
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$131
Meloxicam18$65
Ciprofloxacin Hcl12$59

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →